Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Phase IV Trial of Individualized Care Versus Standard Care, in the Prevention of Chemotherapy Induced Nausea and Vomiting in Breast Cancer Patients. The EPIC Study

NCT01913990 is registered in ClinicalTrials.gov with Ottawa Hospital Research Institute as lead sponsor.

NCT NCT01913990
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01913990 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Phase IV Trial of Individualized Care Versus Standard Care, in the Prevention of Chemotherapy Induced Nausea and Vomiting in Breast Cancer Patients. The EPIC Study
Lead sponsor
Ottawa Hospital Research Institute
Phase
Phase 4
Overall status
Unknown status
Start date
September 30, 2011
Completion date
December 31, 2017
Enrollment
323 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

emesis